The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anidulafungin Market Research Report 2025
Synopsis
Anidulafungin (INN) (trade names Eraxis, Ecalta) is a semisynthetic echinocandin used as an antifungal drug. It was previously known as LY303366. It may also have application in treating invasive Aspergillus infection.
The global Anidulafungin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Anidulafungin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anidulafungin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Anidulafungin in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Anidulafungin include Pfizer. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anidulafungin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anidulafungin.
Report Scope
The Anidulafungin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anidulafungin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anidulafungin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Segment by Type
50 mg per vial
100 mg per vial
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anidulafungin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Anidulafungin (INN) (trade names Eraxis, Ecalta) is a semisynthetic echinocandin used as an antifungal drug. It was previously known as LY303366. It may also have application in treating invasive Aspergillus infection.
The global Anidulafungin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Anidulafungin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anidulafungin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Anidulafungin in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Anidulafungin include Pfizer. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anidulafungin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anidulafungin.
Report Scope
The Anidulafungin market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anidulafungin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anidulafungin companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Segment by Type
50 mg per vial
100 mg per vial
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anidulafungin companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anidulafungin Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 50 mg per vial
1.2.3 100 mg per vial
1.3 Market by Application
1.3.1 Global Anidulafungin Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anidulafungin Market Perspective (2019-2030)
2.2 Anidulafungin Growth Trends by Region
2.2.1 Global Anidulafungin Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anidulafungin Historic Market Size by Region (2019-2024)
2.2.3 Anidulafungin Forecasted Market Size by Region (2025-2030)
2.3 Anidulafungin Market Dynamics
2.3.1 Anidulafungin Industry Trends
2.3.2 Anidulafungin Market Drivers
2.3.3 Anidulafungin Market Challenges
2.3.4 Anidulafungin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anidulafungin Players by Revenue
3.1.1 Global Top Anidulafungin Players by Revenue (2019-2024)
3.1.2 Global Anidulafungin Revenue Market Share by Players (2019-2024)
3.2 Global Anidulafungin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anidulafungin Revenue
3.4 Global Anidulafungin Market Concentration Ratio
3.4.1 Global Anidulafungin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anidulafungin Revenue in 2023
3.5 Anidulafungin Key Players Head office and Area Served
3.6 Key Players Anidulafungin Product Solution and Service
3.7 Date of Enter into Anidulafungin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anidulafungin Breakdown Data by Type
4.1 Global Anidulafungin Historic Market Size by Type (2019-2024)
4.2 Global Anidulafungin Forecasted Market Size by Type (2025-2030)
5 Anidulafungin Breakdown Data by Application
5.1 Global Anidulafungin Historic Market Size by Application (2019-2024)
5.2 Global Anidulafungin Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Anidulafungin Market Size (2019-2030)
6.2 North America Anidulafungin Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Anidulafungin Market Size by Country (2019-2024)
6.4 North America Anidulafungin Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anidulafungin Market Size (2019-2030)
7.2 Europe Anidulafungin Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Anidulafungin Market Size by Country (2019-2024)
7.4 Europe Anidulafungin Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anidulafungin Market Size (2019-2030)
8.2 Asia-Pacific Anidulafungin Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Anidulafungin Market Size by Region (2019-2024)
8.4 Asia-Pacific Anidulafungin Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anidulafungin Market Size (2019-2030)
9.2 Latin America Anidulafungin Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Anidulafungin Market Size by Country (2019-2024)
9.4 Latin America Anidulafungin Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anidulafungin Market Size (2019-2030)
10.2 Middle East & Africa Anidulafungin Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Anidulafungin Market Size by Country (2019-2024)
10.4 Middle East & Africa Anidulafungin Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Anidulafungin Introduction
11.1.4 Pfizer Revenue in Anidulafungin Business (2019-2024)
11.1.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Anidulafungin Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 50 mg per vial
Table 3. Key Players of 100 mg per vial
Table 4. Global Anidulafungin Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Anidulafungin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Anidulafungin Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Anidulafungin Market Share by Region (2019-2024)
Table 8. Global Anidulafungin Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Anidulafungin Market Share by Region (2025-2030)
Table 10. Anidulafungin Market Trends
Table 11. Anidulafungin Market Drivers
Table 12. Anidulafungin Market Challenges
Table 13. Anidulafungin Market Restraints
Table 14. Global Anidulafungin Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Anidulafungin Market Share by Players (2019-2024)
Table 16. Global Top Anidulafungin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anidulafungin as of 2023)
Table 17. Ranking of Global Top Anidulafungin Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Anidulafungin Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anidulafungin Product Solution and Service
Table 21. Date of Enter into Anidulafungin Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anidulafungin Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Anidulafungin Revenue Market Share by Type (2019-2024)
Table 25. Global Anidulafungin Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Anidulafungin Revenue Market Share by Type (2025-2030)
Table 27. Global Anidulafungin Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Anidulafungin Revenue Market Share by Application (2019-2024)
Table 29. Global Anidulafungin Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Anidulafungin Revenue Market Share by Application (2025-2030)
Table 31. North America Anidulafungin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Anidulafungin Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Anidulafungin Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Anidulafungin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Anidulafungin Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Anidulafungin Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Anidulafungin Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Anidulafungin Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Anidulafungin Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anidulafungin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Anidulafungin Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Anidulafungin Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Anidulafungin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Anidulafungin Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Anidulafungin Market Size by Country (2025-2030) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Anidulafungin Product
Table 49. Pfizer Revenue in Anidulafungin Business (2019-2024) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Research Programs/Design for This Report
Table 52. Key Data Information from Secondary Sources
Table 53. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anidulafungin Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Anidulafungin Market Share by Type: 2023 VS 2030
Figure 3. 50 mg per vial Features
Figure 4. 100 mg per vial Features
Figure 5. Global Anidulafungin Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Anidulafungin Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Drug store Case Studies
Figure 9. Anidulafungin Report Years Considered
Figure 10. Global Anidulafungin Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Anidulafungin Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Anidulafungin Market Share by Region: 2023 VS 2030
Figure 13. Global Anidulafungin Market Share by Players in 2023
Figure 14. Global Top Anidulafungin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anidulafungin as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Anidulafungin Revenue in 2023
Figure 16. North America Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Anidulafungin Market Share by Country (2019-2030)
Figure 18. United States Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Anidulafungin Market Share by Country (2019-2030)
Figure 22. Germany Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Anidulafungin Market Share by Region (2019-2030)
Figure 30. China Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Anidulafungin Market Share by Country (2019-2030)
Figure 38. Mexico Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Anidulafungin Market Share by Country (2019-2030)
Figure 42. Turkey Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Anidulafungin Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Pfizer Revenue Growth Rate in Anidulafungin Business (2019-2024)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
